- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01585012
Usability Study of the Focus Touch™ Conception System: Semen Collection (Ib2C)
May 4, 2015 updated by: Rinovum Women's Health, Inc.
Phase 2 Human Factors Usability Study of the Focus Touch™ Conception System: Semen Collection
This is a human factors usability study designed to validated usability by obtaining feedback in a home use environment regarding ease of use of the Focus Touch™ Conception System Conceptacle (when used to collect semen) and the instructions for use.
The investigators will collect data to demonstrate that the usability requirements of the conception system as collection device, as determined by Usability Specification: Focus Touch Conception System, ER-000001 have been met.
The ability of the device to be used during sexual intercourse without discomfort or injury to the female participant's vaginal/cervical tissues shall also be taken into account.
Participating couples will be asked to use the Focus Touch™ Conception System Conceptacle (in condom form), using the Instructions For Use, to collect semen during sexual intercourse in a home use environment.
This study will involve sexual intercourse between monogamous, heterosexual couples who are trying to conceive or are on a non-vaginal birth control with which they do not normally use condoms.
Participants will be asked to complete the study and the questionnaire within 3 days of receiving the study packet.
Contact information shall be collected, but participants will only be contacted if they fail to return the questionnaire within the requested timeframe.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Monroeville, Pennsylvania, United States, 15146
- Forbes Regional Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Heterosexual, monogamous couples, of any race or ethnicity, who are sexually active
- 20 - 50 years of age
- Signed Informed Consent
- Past experience with using condoms
- Trying to conceive or using a non-vaginal birth control with which they do not normally use a condom.
Exclusion Criteria:
- Vaginal tract medical interventions with the last three (3) month
- Vaginal prolapse
- Full Hysterectomy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Cervical cap
Collection condom with cervical cap inserted
|
Cervical cap
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The primary objective is to determine if the Focus Touch™ Conception System Conceptacle is functionally acceptable and meets the user's needs and expectations when used in the home during sexual intercourse as a semen collection device.
Time Frame: 4 days
|
Participating couples will be given the Focus Touch™ Conception System Conceptacle.
The Conceptacle will be used during sexual intercourse, in the home, to collect semen.
The device will be used in accordance with the instructions for use.
Participants will be asked to complete the study and the questionnaire within 3 days of receiving the study packet.
Contact information shall be collected, but participants will only be contacted if they fail to return the questionnaire within the requested timeframe.
As a result, this study could take up to 4 days to complete.
|
4 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael J Pelekanos, OB-GYN, Forbes Regional
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (ACTUAL)
March 1, 2012
Study Completion (ACTUAL)
March 1, 2012
Study Registration Dates
First Submitted
April 23, 2012
First Submitted That Met QC Criteria
April 24, 2012
First Posted (ESTIMATE)
April 25, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
May 6, 2015
Last Update Submitted That Met QC Criteria
May 4, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11-045
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Yuzuncu Yil UniversityCompletedUnexplained Infertility | Female Infertility | Anovulatory InfertilityTurkey (Türkiye)
Clinical Trials on Cervical cap (Focus Touch™ Conception System)
-
Orthofix Inc.TerminatedCervical Degenerative Disc DiseaseUnited States
-
University at BuffaloCompletedDeep Vein Thrombosis | Pulmonary EmbolismUnited States
-
Medtronic Spinal and BiologicsCompleted
-
Medtronic Spinal and BiologicsCompletedRadiculopathy | Myelopathy | Cervical Degenerative Disc DiseaseUnited States
-
Medtronic DiabetesCompletedType 1 Diabetes MellitusUnited States
-
Centre Hospitalier Universitaire de NīmesUniversity Hospital, LimogesCompletedColorectal Cancer | Adenoma | Intestinal PolypsFrance
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloActive, not recruitingGenitourinary Symptoms | Postmenopausal Symptoms | Postmenopausal Atrophic VaginitisBrazil
-
TriReme Medical, LLCActive, not recruitingIschemia | Intermittent Claudication | Peripheral Artery Disease (PAD)New Zealand, United States, Austria, Germany
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloActive, not recruitingBreast Cancer | Vaginal Atrophy | Vulva; AtrophyBrazil
-
Asan Medical CenterUnknownHypoxic Ischemic EncephalopathyKorea, Republic of